Australia Stock Exchange release from AMPLIA THERAPEUT : AMP945 Improves Survival in Human Pancreatic Cancer Model
Australia Stock Exchange release from AMPLIA THERAPEUT ATX.AX : AMP945 Improves Survival in Human Pancreatic Cancer Model
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement